From Reporting to Resilience: The New ESG Agenda for Healthcare Infrastructure

From Reporting to Resilience: The New ESG Agenda for Healthcare Infrastructure
Aurthor: Sidharth Nanda
 
Healthcare infrastructure - the buildings, laboratories, equipment and the essential utilities and systems that keep them operating - is a critical service platform. In the UAE, rising heat risk, rapid sector growth, investor expectations and the evolution of capital-market ESG guidance are pushing providers to treat ESG less as a reporting exercise and more as operational resilience: keeping care continuous, safe and affordable while reducing cost volatility and risk.
What do we mean by “healthcare infrastructure”?
The World Health Organization (WHO) describes health care infrastructure as all buildings where health services are delivered, as well as facilities that support delivery (for example laboratories and blood banks), and the underlying systems needed to run them, including water and electricity. In practical terms, this also extends to:
  • medical equipment and critical assets (e.g., imaging, sterile services, cold chain),
  • digital infrastructure (clinical systems, data platforms, cybersecurity controls), and
  • the health supply chain (procurement, logistics, waste contractors, and key suppliers).
Trends shaping ESG in healthcare infrastructure (UAE and global)
Five trends are making ESG increasingly “operational” for healthcare providers:

Climate and heat resilience is becoming a board topic.

Extreme heat is a predictable and preventable health risk, and health facilities must be prepared for heat-related disruptions, from cooling load stress to workforce safety. Climate-resilient health care facility guidance increasingly links resilience with energy, water, sanitation and waste systems.

Decarbonisation is converging with cost and reliability.

Hospitals are energy-intensive by design (cooling, ventilation, medical equipment and 24/7 operations). Energy efficiency is widely recognised as one of the fastest and most cost-effective mitigation levers, and in healthcare it also improves asset reliability by reducing strain on critical systems.

Water and waste are moving up the risk register.

Sterilisation, cooling towers and clinical processes drive material water demand, while biomedical waste requires robust segregation, treatment and traceability. Vendor governance matters as much as on-site practices.

Investor-facing disclosure expectations are maturing in the UAE.

For listed entities, ADX ESG disclosure guidance and metrics frameworks are raising expectations for consistent, decision-useful ESG data (not just narrative). This is influencing healthcare groups as they standardise KPIs, controls and evidence.

Digitalisation is expanding both opportunity and risk.

Digital supply chain and clinical system transformation can improve efficiency and patient outcomes, but it amplifies cyber, privacy and third-party risk. Governance and assurance readiness become differentiators.
What “good” looks like: ESG built into infrastructure decisions
High-performing programmes treat ESG as part of core infrastructure management - planning, build/retrofit, operations, procurement and oversight. Practical patterns include:

Environmental performance that protects care delivery
  • Energy optimisation (HVAC/chiller efficiency, building management systems, retro-commissioning) prioritised around critical clinical loads.
  • Resilience-ready power (renewables where feasible, storage/backup readiness, preventative maintenance tied to risk).
  • Water stewardship (leak detection, efficient fixtures, cooling optimisation, and monitoring of high-demand processes).
  • Clinical and biomedical waste governance (segregation, vendor qualification, treatment/disposal traceability).
Social outcomes embedded in estate and operating decisions
  • Patient safety and quality governance linked to facility design, infection prevention and operational controls.
  • Workforce sustainability (training pathways, wellbeing, retention, safe working conditions - including heat stress protections).
  • Access and equity lenses (service design, communications, affordability mechanisms, accessibility for people of determination).
Governance that enables credible disclosure (and reduces greenwashing risk)
  • Clear accountability (board oversight, executive ownership, escalation and decision forums).
  • ESG data model and controls (definitions, ownership, evidence retention, and audit trails).
  • Third-party and supply chain governance (waste vendors, critical suppliers, labour and ethics standards).
  • Cybersecurity and privacy-by-design for clinical and patient data environments.
Case studies: what leading UAE healthcare groups are disclosing
Public disclosures from two large UAE healthcare groups illustrate the direction of travel: clearer targets, stronger governance and increasing use of external benchmarks and assurance.
 

Case study 1: Burjeel Holdings

Selected disclosures and practices (based on public information):
  • ESG strategy and framework articulated publicly, with sustainability content also included in investor reporting (annual report / MD&A).
  • Emissions and longer-term ambition: public targets include progressing Scope 1 and Scope 2 reduction roadmaps, developing Scope 3 accounting strategy and an ambition to reach carbon neutrality by 2040.
  • Use of external benchmarking: Burjeel has publicly referenced an inaugural “AAA” MSCI provisional ESG rating (August 2024).
What appears to work:
  • Translating ESG into measurable, operational metrics (e.g., emissions intensity) that can be tracked year-on-year.
  • Linking ESG narrative to governance and investor materials, which typically increases internal discipline around data quality and controls.
  • Using recognised external benchmarks (ratings/indices) to drive focus and comparability - while treating ratings as a signal, not a substitute for underlying performance.
What the wider industry can take from it:
  • Start with “estate fundamentals”: energy, water and waste management systems, backed by governance and vendor controls.
  • Track intensity metrics (per patient, per bed, per sqm) alongside absolute metrics to make progress comparable across facilities and growth cycles.
  • Publish realistic interim targets and the mechanisms to deliver them (capex roadmap, maintenance regime, procurement standards).

Case study 2: PureHealth

Selected disclosures and practices (based on public information):
  • Standalone sustainability reporting: PureHealth has published a sustainability report covering 2023 performance and has referenced a 2024 Sustainability and Social Impact (SSI) reporting cycle through its annual reporting and investor communications.
  • Alignment with UAE capital-market expectations: PureHealth has stated alignment with international reporting standards and ADX ESG disclosure guidance in its sustainability reporting communications.
  • Targets and credibility mechanisms: public communications have referenced Net Zero ambition and the use of independent assurance for ESG data; PureHealth has also been publicly reported as achieving validation of its Net Zero target by the Science Based Targets initiative (SBTi) and reducing GHG emissions intensity across UAE operations versus a 2022 baseline.
What appears to work:
  • Using a structured SSI/ESG framework that connects “longevity” and healthcare outcomes to operational levers.
  • Raising credibility via assurance of ESG data and alignment to recognised disclosure guidance.
  • Making performance comparable through intensity metrics and baseline disclosure.
What the wider industry can take from it:
  • Treat ESG data like financial data: clear definitions, owners, controls and evidence packs - especially where disclosures influence investors.
  • For Net Zero claims, clarify boundary, baseline year, scope coverage, interim targets and governance; consider third-party validation where appropriate.
  • Integrate clinical quality and patient safety indicators with the “S” narrative to avoid ESG being seen as separate from care outcomes.
What BDO UAE Can Support With (ESG & Sustainability)
Strategy & Governance
  • ESG strategy development aligned to healthcare sector priorities.
  • ESG governance frameworks (board, committees, clinical oversight).
  • ESG policies and procedures integrated into operational functions.
ESG Risk & Compliance
  • Climate‑related physical and transition risk assessments.
  • ESG regulatory alignment (ADX, UAE sustainability directives, global frameworks).
Data, KPIs & Reporting
  • ESG KPI development tailored to medical infrastructure (energy, water, waste, workforce).
  • Sustainability/ESG reporting frameworks and disclosures
Supply Chain & Procurement
  • Sustainable procurement frameworks for medical supplies and equipment.
  • Supplier ESG risk assessments and due‑diligence processes.
  • Localisation and responsible sourcing strategies.
Monitoring & Improvement
  • ESG dashboards and performance tracking.
  • Periodic ESG maturity reviews and target recalibration.
Conclusion

In healthcare, ESG is ultimately a resilience discipline. The providers that advance fastest are those that translate sustainability into infrastructure choices: how energy and water systems are run, how waste and suppliers are governed, how staff are supported, and how data is controlled. Public disclosures from UAE healthcare leaders already indicate the next frontier: clearer targets, stronger governance, and increased use of assurance and external validation. For the wider sector, the opportunity is to standardise “what good looks like” and embed it into everyday decisions - without compromising care.

A practical next step for many organisations is to align leadership on the ESG topics that matter most to their care model, establish a defensible baseline, and then move into targeted initiatives backed by measurable KPIs and robust governance.

Let’s shape the future of healthcare—together.

Contact BDO UAE’s ESG Advisory Team to begin your sustainability journey.

References (public sources)

  1. WHO (2023). Strategic health infrastructure investments to support universal health coverage (Technical Brief). https://cdn.who.int/media/docs/default-source/universal-health-coverage/who-uhl-technical-brief-infrastructure.pdf
  2. WHO (2024). Climate change: heat and health (fact sheet). https://www.who.int/news-room/fact-sheets/detail/climate-change-heat-and-health
  3. ADX. ESG Disclosure Guidance for Listed Companies (English PDF). https://www.adx.ae/-/media/adx/related-documents/sustainability/esg-disclosure-guidance-for-listed-companies---english.pdf
  4. Burjeel Holdings. Annual Report 2024 (PDF). https://burjeelholdings.com/wp-content/uploads/2025/04/ENG-BH-Annual-Report-2024.pdf
  5. Burjeel Holdings. ESG Framework page. https://burjeelholdings.com/sustainability/esg-framework/
  6. Burjeel Holdings. Healthy Environment page (targets and metrics). https://burjeelholdings.com/sustainability/environment/
  7. PureHealth. Annual Report and Accounts 2024 (English PDF). https://purehealth.ae/wp-content/uploads/2025/04/Purehealth-Annual-Report-2024_English.pdf
  8. PureHealth. Sustainability Report 2023 (PDF). https://longevityoftheplanet.com/wp-content/uploads/2024/09/PureHealth%20-%202023%20Sustainability%20Report%20-%20Longevity%20of%20the%20Planet.pdf
  9. WAM (2025). PureHealth secures ESG rankings, cuts emissions intensity (article). https://www.wam.ae/en/article/bmbenx4-purehealth-secures-esg-rankings-cuts-emissions
  10. PureHealth. FY 2024 earnings release / reporting communication (PDF). https://purehealth.ae/wp-content/uploads/2024/11/20240930-PureHealth-Earnings-Release-EN.pdf